By Will Feuer

Medtronic posted higher sales for its fiscal second quarter, lifted by growth across all of the medical-device maker's portfolios, especially its medical-surgical and cardiovascular products.

The company reported a profit of $909 million, or 68 cents a share, for the three months ended Oct. 27, compared with $427 million, or 32 cents a share, in the same period last year.

Stripping out one-time items, including amortization, adjusted earnings were $1.25 a share. Analysts surveyed by FactSet had expected $1.18 a share.

Sales rose more than 5% to $7.98 billion, above the $7.93 billion that analysts had expected, according to FactSet.

Revenue rose across Medtronics' four portfolios: Cardiovascular, Neuroscience, Medical Surgical and Diabetes.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

November 21, 2023 07:13 ET (12:13 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Medtronic (NYSE:MDT)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Medtronic
Grafico Azioni Medtronic (NYSE:MDT)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Medtronic